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ABSTRACT 
Background: Little progress has been made in preventing pelvic floor disorders despite their significant 
health and economic impact. Identifying women at risk remains a key element in targeting prevention and 
planning health resource allocation strategies. Although events around the time of childbirth are clinically 
recognized as important predictors, it is difficult to counsel women and intervene around the time of 
childbirth due to an inability to accurately convey a patient’s risk in the presence of multiple risk factors 
and the long time lapse, often decades, between obstetric events and the onset of pelvic floor disorders 
later in life. Prediction models and scoring systems have been used in other areas of medicine to identify 
patients at risk for chronic diseases. Models have been developed for use before delivery that predict 
short-term risk of pelvic floor disorders after childbirth but no models predicting long-term risk exist.  
Objective: To use variables known before and during childbirth to develop and validate prognostic 
models estimating risks of these disorders 12 and 20 years after delivery. 
Study Design: Obstetric variables were collected from two cohorts: 1) women who gave birth in the 
United Kingdom and New Zealand (n=3763) and 2) women from the Swedish Medical Birth Register 
(n=4991). Pelvic floor disorders were self-reported 12 years after childbirth in the UK/NZ cohort and 20 
years after childbirth in the Swedish Register. The cohorts were split so that data during the first half of 
the cohort’s time period were used to fit prediction models and validation was performed from the second 
half (temporal validation). As there is currently no consensus on how to best define pelvic floor disorders 
from a patient’s perspective, we chose to fit the data for each model using multiple outcome definitions 
for prolapse, urinary incontinence, fecal incontinence, 1 or more pelvic floor disorder and 2 or more 
pelvic floor disorders. Model accuracy was measured: 1) by ranking an individual’s risk among all 
subjects in the cohort (discrimination) using a concordance index and 2) by observing whether the 
predicted probability was too high or low (calibration) at a range of predicted probabilities using visual 
plots. 
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Results: Models were able to discriminate between women who developed bothersome symptoms or 
received treatment, at 12 and 20 years respectively, for: pelvic organ prolapse (concordance indices 0.570, 
0.627), urinary incontinence (concordance indices 0.653, 0.689), fecal incontinence (concordance indices 
0.618, 0.676), ≥1 pelvic floor disorders (concordance indices 0.639, 0.675) and ≥2 pelvic floor disorders 
(concordance indices 0.635, 0.619). The discriminatory ability of all models is shown in Table 2. Route of 
delivery and family history of each pelvic floor disorder were strong predictors in most models. Urinary 
incontinence before and during the index pregnancy was a strong predictor for developing all pelvic floor 
disorders in most models 12 years after delivery. The 12 and 20-year bothersome or treatment for 
prolapse models were accurate when providing predictions for risk from 0% to approximately 15%. The 
12-year and 20-year primiparous model began to over-predict when risk rates reached 20%. When 
predicting bothersome symptoms or treatment for urinary incontinence, the 12-year models were accurate 
when predictions ranged from approximately 5% to 60% and 20-year primiparous models were accurate 
between 5% and 80%. For bothersome symptoms or treatment for fecal incontinence, the 12 and 20-year 
models were accurate between 1% and 15% risk and began to over-predict at rates above 15% and 20%, 
respectively.   
Conclusion: Models may provide an opportunity before birth to identify women at low risk of developing 
pelvic floor disorders and institute prevention strategies such as pelvic floor muscle training, weight 
control or elective cesarean section for women at higher risk. Models are provided at: 
http://riskcalc.org/UR_CHOICE/  
 
 
INTRODUCTION  
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Pelvic floor disorders such as pelvic organ prolapse, urinary incontinence and fecal incontinence 
constitute a huge global health problem affecting millions of women throughout the world. The 
prevalence of pelvic floor disorders has been reported to be 46% and many women have more than one.1 
Pelvic floor disorders can have a negative influence on a woman’s well- being, quality of life, body image 
and sexual function, and prevent many from participating in recreational and sporting activities.1, 2  The 
global costs of pelvic floor disorders to health care systems and society are enormous.1, 3 Approximately, 
1 in 5 women will undergo surgery for prolapse or urinary incontinence by age 85.4, 5 Current treatments, 
often surgical, carry risks and relatively high rates of recurrence.6, 7  
Little progress has been made in preventing pelvic floor disorders despite their significant health and 
economic impact.8 Identifying women at risk remains a key element in targeting prevention and planning 
health resource allocation strategies. The etiology of pelvic floor disorders is known to be multifactorial 
and obstetric trauma during childbirth is one of the most important identifiable risk factors.1 Numerous 
epidemiological studies indicate an increased prevalence of pelvic floor disorders with increasing parity 
with the greatest increase in risk attributed to the birth of the first child.1 Although events around the time 
of childbirth are clinically recognized as important predictors, many women undergo the labor and 
delivery process and do not experience long-term pelvic floor dysfunction. At present, it is difficult to 
counsel women and intervene around the time of childbirth due to an inability to accurately convey a 
patient’s risk in the presence of multiple risk factors and the long time lapse, often decades, between 
obstetric events and the onset of pelvic floor disorders later in life. 
Prediction models and scoring systems have been used in other areas of medicine to identify patients at 
risk for chronic diseases.9, 10 Models have been developed for use before delivery that predict short-term 
risk of pelvic floor disorders after childbirth but no models predicting long-term risk exist.11, 12 The aims 
of this study were to construct and validate models capable of predicting the development of pelvic floor 
disorders 12 and 20 years after delivery using data from two large independent international cohort 
studies.13, 14 Such models have potential to provide individual women more accurate predictions than the 
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current standard of care given: 1) the paucity of existing tools, 2) the large amount of variability in the 
predicted rates of pelvic floor disorders provided by clinicians in practice and 3) the increasing evidence 
that clinical prediction models consistently show superiority over expert clinicians because they avoid 
common cognitive biases.15, 16  
METHODS 
This study is reported using methods set forth in the Transparent Reporting of a multivariable prediction 
model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement.17 The study population 
consisted of two longitudinal, prospective cohort studies. The PROlapse and incontinence LONG-term 
(ProLong) study aimed to determine whether delivery mode was predictive of pelvic floor disorders in 
10,989 primiparous and multiparous women 12 years after the index birth.14 The second cohort was the 
Swedish Pregnancy, Obesity and Pelvic Floor (SwePOP) study. The aim of SwePOP was to compare the 
prevalence of pelvic floor disorders in a cohort of 10,117 primiparous women identified from the Swedish 
Medical Birth Register 20 years after one delivery.13, 18 Both studies were designed to investigate delivery 
mode as a predictor of pelvic floor disorders and therefore, captured key maternal, labor and delivery 
variables that were known at that time to be potential risk factors of pelvic floor disorders. Study details 
have been previously published and are summarized in Figure 1.14, 18  
In the ProLong study, prolapse symptoms were measured using the validated Pelvic Organ Prolapse 
Symptom Score.19 Urinary and fecal incontinence questions were designed by the study team because at 
the time of recruitment (1993/94) there were no suitable validated questionnaires on incontinence. Family 
history was measured using a response of either “yes” or “no” to, “Have any of your blood relatives ever 
had a prolapse?” and “If yes, how are they related to you (eg. mother, sister)?” In the SwePOP study, 
prolapse was defined using the validated sPOP questionnaire,20 urinary incontinence using the Sandvik 
severity scale,21 and fecal incontinence using the Wexner score.22 Family history was measured using a 
response of either yes or no to each of the following items, “Has your mother suffered from urinary 
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leakage?”, “Has your mother suffered from prolapse?” and “Has your mother suffered from leakage of 
flatus/gas or feces?” Each study received ethics committee approval at all centers. Written informed 
consent was obtained from participants in both studies. 
In order to allow for temporal validation, each cohort was temporally split so that women giving birth in 
the first half of the cohort’s time period were considered for the training dataset and used to build each 
model. For the ProLong dataset, data from primiparous and multiparous women who gave birth between 
September 11, 1993 and May 1, 1994 and responded at 12 years (N=2,095) were used to build models to 
predict 12-year outcomes for women who gave birth between May 2, 1994 and November 11, 1994 
(N=1,668). Similarly, in the SwePOP dataset, data from primiparous women who gave birth between 
January 1, 1985 and June 30, 1987 (N=2,607) were used to build models to predict 20-year outcomes for 
women who gave birth between July 1, 1987 and December 31, 1988 (N=2,384). For each training 
dataset, the multiple imputation using chained equations (MICE) method was used to calculate missing 
values for predictors.23 Predictors for the test dataset and outcomes for all models were based on actual, 
not imputed values.  
As there is currently no consensus on how to best define pelvic floor disorders from a patient’s 
perspective, we chose to fit the data for each model using multiple outcome definitions for prolapse, 
urinary incontinence, fecal incontinence, 1 or more pelvic floor disorder and 2 or more pelvic floor 
disorders. We developed models to predict: 1) the presence of “any symptoms” regardless of severity; 2) 
the presence of bothersome symptoms; 3) treatment for the disorder, or 4) the combination of either 
bothersome symptoms or receiving treatment for each disorder (prolapse, urinary incontinence, fecal 
incontinence) and their combination (any pelvic floor disorder or 2 or more pelvic floor disorders) (Table 
1 footnote). Data are only presented for category 4) above, and all remaining outcomes are available in 
the supplementary results. 
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Multiple logistic regression models were fit to the training data consisting of the full set of candidate 
predictors and each outcome. Harrell’s “Model Approximation” process of backwards elimination was 
used to rank the variables in order of importance starting from the full model using a bootstrap bias-
corrected concordance index as the stopping criteria to find the best parsimonious model.24 Variables with 
individual p-values that were greater than 0.05 were left in the model if they offered information to 
improve the overall model accuracy. Removal was evaluated by determining which variable had the 
smallest effect on the R2 and was stopped when the bootstrap concordance index had a change less than 
0.01. This process provided a parsimonious model for each outcome.  
Model accuracy was measured: 1) by ranking an individual’s risk among all subjects in the cohort 
(discrimination) using a concordance index and 2) by observing whether the predicted probability was too 
high or low (calibration) at a range of predicted probabilities using visual plots. Once the models were 
built and prior to performing temporal validation, all concordance indices were internally validated using 
1,000 bootstrap samples to adjust for overfitting biases on the initial build and 95% confidence intervals 
were calculated. Calibration curves along with distributions of predicted probabilities of those with and 
without each outcome were generated to visually observe how close model predictions were to actual 
predictions.  
Temporal validation requires a prognostic model to produce accurate predictions when it is tested in 
cohorts from different time periods. It is a prospective form of validation recommended when an 
independent validation data set with similar obstetric populations and long-term outcomes is not 
available.17 Models were developed using antepartum variables, previous delivery variables and delivery 
mode. We specifically investigated whether events that occurred at the time of delivery (e.g. episiotomy, 
perineal laceration) significantly improved the accuracy of prediction by comparing the difference in 
accuracy using a bootstrap method from their respective receiver operating characteristic curve.  
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All models were combined into a single integrated web-based calculator so that a complete set of 
predictors can be entered and outcomes for all pelvic floor disorders are presented. All analyses were 
performed using R Version 3.2.3 (2015-12-10). 
RESULTS 
Baseline characteristics and outcomes were available in 3763 participants in the ProLong study 12 years 
after their index birth and 4991 of the participants in the SwePOP study 20 years after their first and only 
birth. The overall rates of pelvic floor disorders with 95% confidence intervals 12 and 20 years after 
delivery are described in Table 1. The descriptive statistics of candidate predictors among each study 
cohort are provided in Supplemental Table 1.  
Model Discrimination 
Forty separate models were developed from the two cohorts for use including 20 models that predict 
outcomes in primiparous and multiparous women 12 years after delivery and 20 models that predict 
outcomes in primiparous women 20 years after delivery. All 40 final models included predictors known 
or estimated prior to delivery along with actual route of delivery. Each model’s discriminatory ability is 
shown in Table 2. Models were able to discriminate between women who developed bothersome 
symptoms or received treatment, at 12 and 20 years respectively, for pelvic organ prolapse (concordance 
indices 0.570, 0.627), urinary incontinence (concordance indices 0.653,0.689), fecal incontinence 
(concordance indices 0.618,0.676), one or more pelvic floor disorders (concordance indices 0.639,0.675) 
and two or more pelvic floor disorders (concordance indices 0.635,0.619).  
 
Model Calibration 
Calibration curves for the models from the two cohorts predicting bothersome pelvic floor disorders or 
the need for treatment at 12 and 20 years are shown in Figure 2. The majority of models predicted 
probabilities close to actual probabilities throughout a range of clinically useful predictions but began to 
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over-predict at higher probabilities. The 12 and 20-year bothersome or treatment for prolapse models 
were accurate when providing predictions for risk from 0% to approximately 15% (Table 1 average risk 
7-10%). The 12-year and 20-year primiparous model began to over-predict when risk rates reached 20%. 
When predicting bothersome symptoms or treatment for urinary incontinence, the 12-year models were 
accurate when predictions ranged from approximately 5% to 60% (Table 1 average risk 23-31%) and 20-
year primiparous models were accurate between 5% and 80% (Table 1 average risk 18-20%). For 
bothersome symptoms or treatment for fecal incontinence, the 12 and 20-year models were accurate 
between 1% and 15% risk (Table 1 average risk 3-7%). The bothersome or treatment for fecal 
incontinence models began to over-predict at rates above 15% and 20% for the 12 and 20-year model, 
respectively.  A complete set of calibration curves for models predicting all outcomes at 12 and 20 years 
are available in Supplemental Figures 1A and 1B. An online calculator (http://riskcalc.org/UR_CHOICE/) 
is available for clinical use and two examples of predictions for a hypothetical average and high-risk 
patient are displayed. (Supplemental Figure 2A and 2B) 
Model Variables 
The relative influence of each predictor for models predicting the combination of bothersome symptoms 
or receiving treatment for each disorder is summarized in Figure 3. Route of index delivery, number of 
previous births and family history of each pelvic floor disorder were the most influential in most models. 
Any urinary incontinence before pregnancy was an influential predictor for women developing 
bothersome prolapse or having treatment for prolapse, urinary incontinence and fecal incontinence 12 
years after delivery. In primiparous women at 20 years, having a vaginal delivery was significantly 
associated with increasing a woman’s 20-year risk of developing bothersome or treatment for prolapse 
and urinary incontinence. The strength of association among the predictors for all models are provided in 
Supplemental Figures 3A and 3B. 
DISCUSSION 
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Most women undergo childbirth without experiencing bothersome pelvic floor disorders or requiring 
treatment for pelvic floor disorders throughout their lifespan. More recently, women are seeking more 
evidence-based informed decision making prior to labor that will reassure them that the birthing process 
will not be detrimental to their long-term health. Informing a woman of her risks of pelvic floor disorders 
along with other risks of childbirth, is in accordance with the judgment of the 2015 United Kingdom 
Supreme Court case and supports a woman’s autonomy and her right to informed choice regarding her 
care in pregnancy and childbirth.25 A major barrier to effective prevention of pelvic floor disorders is the 
inability to identify “at risk” women to target prevention programs. Childbirth is among the most 
important and consistent risk factor for pelvic floor disorders, however, in most women, clinically 
relevant symptoms and treatment occur decades later in life.26 The models presented, while not perfect, 
predict better than chance and are able to discriminate between those with and without pelvic floor 
disorders 51-75% of the time. Traditionally, when estimates of risk are provided to women during 
pregnancy, they are based on a clinician’s knowledge and experience, by quoting overall average 
population risk to all women, or by heuristically assigning individuals into crude categories such as low 
or high-risk groups. Even when high-level evidence exists, estimates are typically provided without 
accurately accounting for the specifics of a woman’s unique characteristics such as her age, parity, co-
morbidities and family history. The development and implementation of accurate clinical tools that go 
beyond clinical judgment and predict an individual woman’s future risk of developing pelvic floor 
disorders will be an essential component of any primary prevention strategy and will help reassure the 
majority of mothers when serious pelvic floor damage is not strongly predicted.  
We developed models for multiple definitions of each pelvic floor disorder outcome, combined into a 
single, easy-to-use, on-line calculator. The models allow calculation of risk that includes past delivery 
characteristics and planned route of delivery (vaginal versus cesarean section). The role of elective 
cesarean section in the prevention of pelvic floor disorders remains controversial and, given the potential 
maternal and fetal risks, is unlikely to be an effective prevention strategy for most women.26, 27 It has been 
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estimated, for instance, that approximately 9 cesarean sections would be necessary to prevent urinary 
incontinence in one primiparous woman of average risk.18 However, a strategy of offering cesarean 
section to women who are at substantially higher than average risk for pelvic floor disorders may be a 
more appropriate and effective prevention strategy. At what risk threshold that occurs is currently 
unknown however, and must be balanced against the risks of cesarean section and, in many cases, 
multiple repeat cesarean deliveries, especially since maximum protection may occur when all deliveries 
are by Cesarean.14, 26 After delivery, the models are intended for women who may be considering other 
secondary prevention strategies. Prevention strategies such as pelvic floor muscle training and weight loss 
programs offer promise but have not been adequately studied long-term or many years after delivery.28 
Compliance with long-term prevention programs is a significant challenge and may be improved by 
informing women about their individual risk of developing the disorders.29  
 
The major strengths of this analysis are the application of predictive analytics to two large well-described 
cohorts of women that collected common maternal and obstetrical variables and similarly defined pelvic 
floor disorder outcomes 12 and 20 years after delivery. While not racially diverse, together these cohorts 
do provide important geographic and cultural diversity, which are important for conditions affecting 
quality of life. However, there are important differences in the two cohorts. The ProLong dataset includes 
primiparous and multiparous women and reports outcomes at 12 years after delivery, while the SwePOP 
study included only primiparous women and reported outcomes at 20 years after delivery. Because of 
these differences, we chose not to develop our prediction models in one cohort and then externally 
validate them in the other as is commonly done. Instead, we performed temporal validation in each 
separate cohort, which is a stronger approach than the more commonly performed random splitting of a 
dataset into a development and validation cohort.17  
 
An important limitation of our models is that they are not perfect. In spite of this, they advance our 
current abilities to predict an individual’s risk of developing pelvic floor disorders many years after 
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childbirth better than providing highly variable, average event rates. The models in this analysis provide 
similar discrimination to other predictive models currently used in clinical practice whose concordance 
indices generally range from 0.6 to 0.8 including widely-used models such as the National Cancer 
Institute Gail model for prediction of Breast Cancer risk (concordance index 0.59) and the Framingham 
Cardiovascular Risk Model (concordance index 0.72).9, 30 While the models developed in this analysis 
were well calibrated at clinical decision-making thresholds, some models provide higher than actual 
probabilities when rates of actual outcomes are high and where there were fewer outcome events 
available.  
 
In summary, the models provide individualized prediction of risk of developing pelvic floor disorders 12 
and 20 years after delivery using maternal and obstetrical variables available prior to childbirth. These 
models should help identify high-risk women in whom prevention strategies such as pelvic floor muscle 
training and weight control or elective cesarean section might be targeted. Ideally, external validation of 
the models should be conducted when and if other large cohorts with similar follow-up become available.   
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Table 1 Overall rates of pelvic floor disorders with 95% confidence intervals in primiparous and multiparous women 12 years after childbirth in 
the ProLong study and in primiparous women 20 years after childbirth in the SwePop study 
   Any 
 
Bothersome 
 
Treatment 
 
Bothersome or 
Treatment 
 Parity N % (95% CI) N % (95% CI) N % (95% CI) N % (95% CI) 
Pelvic organ prolapse
+
        
12-years 0 291 17% (15.1%, 18.7%) 102 6% (4.8%, 7.0%) 28 2% (1.2%, 2.6%) 126 8% (7.0%, 9.8%) 
20-years 0 646 13% (12.1%, 14.0%) 300 6% (5.4%, 6.7%) 73 1.5% (1.2%, 1.9%) 346 7% (6.6%, 8.1%) 
12-years ≥1 347 17% (15.4%, 18.7%) 111 5% (4.5%, 6.4%) 61 3% (2.6%, 4.3%) 159 9% (7.6%, 10.3%) 
          
Urinary incontinence
++
        
12-years 0 877 51% (48.5%, 53.3%) 380 22% (20.2%, 24.2%) 83 5% (3.9%, 6.0%) 423 25% (23.2%, 27.4%) 
20-years 0 1895 38% (36.9%, 39.6%) 822 17% (15.7%, 17.8%) 163 3% (2.9%, 3.9%) 902 19% (17.9%, 20.1%) 
12-years ≥1 1103 54% (52.0%, 56.4%) 510 25% (23.5%, 27.3%) 113 6% (4.7%, 6.8%) 564 29% (26.8%, 30.8%) 
          
Fecal incontinence
+++
        
12-years 0 203 12% (10.3%, 13.4%) 42 2% (1.7%, 3.2%) 37 2% (1.5%, 2.9%) 68 4% (3.2%, 5.1%) 
20-years 0 671 14% (12.6%, 14.5%) 112 2% (1.8%, 2.7%) 54 1% (0.8%, 1.4%) 145 3% (2.5%, 3.5%) 
12-years ≥1 283 14% (12.5%, 15.5%) 74 4% (2.8%, 4.5%) 56 3% (2.1%, 3.6%) 109 6% (4.5%, 6.6%) 
          
≥1 Pelvic floor disorders        
12-years 0 1031 60% (57.7%, 62.3%) 461 27% (25.0%, 29.2%) 132 9% (7.6%, 10.6%) 528 35% (32.4%, 37.2%) 
20-years 0 2322 47% (45.7%, 48.5%) 1051 22% (20.3%, 22.7%) 265 6% (5.1%, 6.5%) 1163 25% (24.0%, 26.5%) 
12-years ≥1 1255 62% (59.7%, 63.9%) 590 29% (27.4%, 31.4%) 197 12% (10.1%, 13.1%) 680 38% (35.8%, 40.3%) 
          
≥2 Pelvic floor disorders        
12-years 0 298 17% (15.5%, 19.1%) 60 3.5% (2.6%, 4.4%) 15 1% (0.4%, 1.4%) 74 4% (3.5%, 5.4%) 
20-years 0 743 15% (14.0%, 16.0%) 167 3% (2.9%, 3.9%) 25 0.5% (0.3%, 0.7%) 185 4% (3.3%, 7.1%) 
12-years ≥1 406 20% (18.3%, 21.7%) 97 5% (3.9%, 5.7%) 31 1.5% (1.0%, 2.1%) 120 6% (5.1%, 7.2%) 
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+ Pelvic organ prolapse was defined at 12 years using responses to, “Do you have a feeling of something coming down from or in your vagina?” 
Any pelvic organ prolapse was defined as responses: occasionally, sometimes, most of the time, or all of the time. Bothersome pelvic organ 
prolapse was defined as responses: sometimes, most of the time, or all of the time. At 20 years, pelvic organ prolapse was defined using responses 
to, “Do you have a feeling of something bulging from your vagina?” Any pelvic organ prolapse was defined as responses: infrequently, 
sometimes, or often. Bothersome pelvic organ prolapse was defined as responses of sometimes or often. 
++ Urinary incontinence was defined at 12 years using responses to, “Do you ever lose urine when you don’t mean to?” and if yes, “in the last 
month how often has this happened, on average?” Any urinary incontinence was defined using responses: < 2x per month, weekly, or 3 or more 
times a day and bothersome urinary incontinence was defined as responses: weekly or 3 or more times a day. At 20 years, urinary incontinence 
was defined using responses to, “Do you have involuntary leakage of urine?” and if yes, “how often has this happened, on average?” Any 
incontinence was defined as responses: < 2x per month, weekly, 3 or more times a day and bothersome urinary incontinence was defined as 
responses: weekly or 3 or more times a day. 
+++ Fecal incontinence was defined at 12 years using responses to the question, “Do you ever lose control of bowel motions (stool/faeces) from 
your back passage in between visits to the toilet?” Any fecal incontinence was defined as responses: occasionally, sometimes, most of the time, or 
all of the time. Bothersome FI was defined as responses most of the time and all of the time. At 20 years, having fecal incontinence was defined as 
responses to the Wexner scale questions, “Do you have involuntary leakage of solid faeces?” or “Do you have involuntary leakage of liquid 
faeces?” Any fecal incontinence was defined as responses to either question as: less than once a month (rarely), once a month but less than once a 
week (sometimes), greater than once a week but less than once a day (usually) or once or more every day (always). Bothersome fecal incontinence 
was defined using the question, “Has involuntary leakage of liquid or solid faeces influenced your feeling of frustration?” Responses of 
moderately or very much were considered bothersome while responses of not at all or a little were not bothersome. 
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Table 2 The discriminatory ability of models predicting risk of pelvic floor disorders 12 and 
20 years after birth 
Outcome Year 
Model Build 
Temporal 
Validation 
Concordance 
index 
95% CI 
Concordance 
index 
Pelvic organ Prolapse     
Any  
12 0.623 (0.591, 0.653) 0.598 
20 0.680 (0.648, 0.712) 0.619 
Bothersome  
12 0.660 (0.612, 0.706) 0.598 
20 0.736 (0.695, 0.779) 0.606 
Treatment  
12 0.734 (0.667, 0.804) 0.560 
20 0.809 (0.739, 0.870) 0.751 
Bothersome or 
Treatment 
12 0.644 (0.603, 0.683) 0.570 
20 0.751 (0.714, 0.791) 0.627 
Urinary Incontinence      
Any 
12 0.672 (0.650, 0.696) 0.641 
20 0.714 (0.692, 0.734) 0.695 
Bothersome 
12 0.702 (0.677, 0.730) 0.640 
20 0.691 (0.665, 0.717) 0.684 
Treatment 
12 0.651 (0.602, 0.702) 0.712 
20 0.685 (0.625, 0.745) 0.634 
Bothersome or 
Treatment 
12 0.704 (0.679, 0.731) 0.653 
20 0.698 (0.673, 0.724) 0.689 
Fecal Incontinence     
Any 
12 0.605 (0.570, 0.636) 0.586 
20 0.648 (0.619, 0.677) 0.624 
Bothersome 
12 0.640 (0.569, 0.710) 0.638 
20 0.720 (0.658, 0.788) 0.658 
Treatment 
12 0.687 (0.620, 0.750) 0.542 
20 0.674 (0.571, 0.759) 0.642 
Bothersome or 
Treatment  
12 0.670 (0.616, 0.721) 0.618 
20 0.701 (0.644, 0.759) 0.676 
≥ 1 Pelvic Floor Disorder      
Any 
12 0.664 (0.643, 0.688) 0.650 
20 0.700 (0.681, 0.719) 0.685 
Bothersome  
12 0.686 (0.663, 0.713) 0.643 
20 0.693 (0.668, 0.717) 0.667 
Treatment 
12 0.670 (0.628, 0.710) 0.649 
20 0.656 (0.614, 0.698) 0.623 
Bothersome or 
Treatment 
12 0.687 (0.661, 0.711) 0.639 
20 0.698 (0.674, 0.722) 0.675 
≥2 Pelvic Floor 
Disorders 
 
   
Any 
12 0.648 (0.618, 0.677) 0.581 
20 0.702 (0.673, 0.729) 0.676 
Bothersome  12 0.730 (0.680, 0.781) 0.661 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 21
Outcome Year 
Model Build 
Temporal 
Validation 
Concordance 
index 
95% CI 
Concordance 
index 
  20 0.760 (0.707, 0.808) 0.621 
Treatment 12 0.738 (0.650, 0.831) 0.711 
  20 0.600 (0.507, 0.744) 0.513 
Bothersome or 
Treatment 
12 0.706 (0.644, 0.751) 0.635 
20 0.753 (0.705, 0.802) 0.619 
 
Year 12 includes data from the ProLong dataset and year 20 includes data from SwePop dataset  
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Supplemental Table 1 Candidate predictors of pelvic floor disorders in the Swedish pregnancy, 
obesity and pelvic floor study and the prolapse and incontinence long-term study 
Variables 
 ProLong 
N = 3,763 
SwePop 
N = 4,991 
Maternal Age at Delivery 29 (26, 32) 29 (25, 34) 
Missing 0 (0%) 0 (0%) 
Maternal Pre-Pregnancy Weight (kg) 60 (54, 67) 62 (56, 70) 
Missing 718 (19%) 702 (14%) 
Maternal Height (cm) 163 (159, 168) 167 (163, 170) 
Missing 44 (1%) 22 (0%) 
Number of Previous Births 1 (0, 1) NA 
Missing 5 (0%)  
0 1723 (46%)  
1 1389 (37%)  
2 453 (12%)  
3 144 (4%)  
≥ 4 49 (1%)  
Route of Delivery (Index Birth)   
Vaginal Unassisted 2556 (68%) 3061 (61%) 
Vacuum 193 (5%) 726 (15%) 
Forceps 401 (11%) 22 (0%) 
C-Section Elective 271 (7%) 764 (15%) 
C-Section Acute 342 (9%) 418 (8%) 
Number of Past Unassisted Vaginal Deliveries 1 (0, 2) NA 
Missing 10 (1%)  
0 1067 (28%)  
1 1404 (37%)  
2 891 (24%)  
3 269 (7%)  
≥4 122 (3%)  
Number of Past Forceps Assisted Deliveries 0 (0, 0) NA 
Missing 10 (1%)  
0 2868 (76%)  
1 835 (22%)  
2 44 (1%)  
3 6 (0%)  
Number of Past Vacuum Assisted Deliveries 0 (0, 0) NA 
Missing 10 (1%)  
0 3515 (93%)  
1 236 (6%)  
2 2 (0%)  
Number of Past Planned C-Sections 0 (0, 0) NA 
Missing 10 (0%)  
0 3370 (90%)  
1 316 (8%)  
2 58 (2%)  
≥ 3 9 (0%)  
Number of Past Acute C-Sections 0 (0, 0) NA 
Missing 10 (0%)  
0 3277 (87%)  
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Variables 
 ProLong 
N = 3,763 
SwePop 
N = 4,991 
1 436 (12%)  
2 &3 40 (1%)  
Number of Any Past Vaginal Deliveries 1 (1, 2) NA 
Missing 10 (1%)  
0 478 (13%)  
1 1583 (42%)  
2 1169 (31%)  
3 365 (10%)  
≥ 4  158 (4%)  
Number of Any Past C-Sections 0 (0, 0) NA 
Missing 10 (1%)  
0 2999 (80%)  
1 570 (15%)  
2 149 (4%)  
≥ 3 35 (1%)  
Family History of POP   
Yes 615 (16%) 676 (14%) 
No 2465 (66%) 3606 (72%) 
Missing 683 (18%) 709 (14%) 
Family History of UI NA  
Yes  1374 (28%) 
No  2852 (57%) 
Missing  765 (15%) 
Family History of FI NA  
Yes  629 (13%) 
No  3600 (72%) 
Missing  762 (15%) 
Pre-Pregnancy UI  NA 
Yes 382 (10%)  
No 3377 (90%)  
Missing 4 (0%)  
UI During Pregnancy  NA 
Yes 386 (10%)  
No 3373 (90%)  
Missing 4 (0%)  
Infant Birthweight (g) 3435 (3080, 3760) 3520 (3160, 3960) 
Missing 75 (2%) 4 (0%) 
Infant Head Circumference (cm) 34.7 (34, 35.7) 35 (34, 36) 
Missing 148 (4%) 107 (2%) 
Twins  NA 
Yes 81 (2%)  
No 3682 (98%)  
Missing 0 (0%)  
Induction Performed  NA 
Yes 646 (17%)  
No 3029 (80%)  
Missing 88 (2%)  
Epidural Used During Labor   
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Variables 
 ProLong 
N = 3,763 
SwePop 
N = 4,991 
Yes 1196 (32%) 1499 (30%) 
No 2524 (67%) 3492 (70%) 
Missing 43 (1%) 0 (0%) 
Episiotomy Performed   
Yes 819 (22%) 510 (10%) 
No 2797 (74%) 4481 (90%) 
Missing 147 (4%) 0 (0%) 
2nd, 3rd, or 4th Degree Perineal Laceration Occurred   
Yes 1430 (38%) 174 (3%) 
No 2186 (58%) 4817 (97%) 
Missing 147 (4%) 0 (0%) 
Time in Second Stage (min.) 28 (8, 85) NA 
Missing 588 (16%)  
 
SwePoP, Swedish Pregnancy, Obesity and Pelvic Floor (SwePOP) study; ProLong, PROlapse and 
incontinence LONG-term (ProLong) study; NA, Not available. 
Data are n (%) or median (interquartile range) unless otherwise specified. Variables are relative to the 
index delivery. 
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